Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DICERNA PHARMACEUTICALS, INC.

(DRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about DICERNA PHARMACEUTICALS, INC.
11/22INSIDER SELL : Dicerna Pharmaceuticals
MT
11/22SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Dicerna Pharm..
PR
11/22Stifel Downgrades Dicerna Pharmaceuticals to Hold From Buy, Adjusts Price Target to $38..
MT
11/19B. Riley Downgrades Dicerna Pharmaceuticals to Neutral from Buy After Announcing $3.3 B..
MT
11/19RBC Downgrades Dicerna Pharmaceuticals to Sector Perform From Outperform, Lifts PT to $..
MT
11/18SHAREHOLDER ALERT : WeissLaw LLP Investigates Dicerna Pharmaceuticals, Inc.
PR
11/18HC Wainwright Downgrades Dicerna Pharmaceuticals to Neutral From Buy, Adjusts PT to $38..
MT
11/18Health Care Stocks Weakening This Afternoon
MT
11/18Dicerna Shares Soar on Takeover by Novo Nordisk
DJ
11/18SHAREHOLDER ALERT : Ademi LLP investigates whether Dicerna Pharmaceuticals, Inc. has obtai..
PR
11/18DICERNA MERGER INVESTIGATION : Halper Sadeh LLP Announces Investigation Into Whether the S..
BU
11/18Health Care Stocks Edge Higher Premarket Thursday
MT
11/18DICERNA PHARMACEUTICALS : Novo Nordisk to Acquire Dicerna - Form 8-K
PU
11/18Novo Nordisk To Acquire Dicerna Pharmaceuticals
MT
11/18Dicerna Pharmaceuticals Enters $3.3 Billion Deal to Be Acquired by Novo Nordisk
MT
More most relevant news
All news about DICERNA PHARMACEUTICALS, INC.
11/22INSIDER SELL : Dicerna Pharmaceuticals
MT
11/22SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Dicerna Pharm..
PR
11/22Stifel Downgrades Dicerna Pharmaceuticals to Hold From Buy, Adjusts Price Target to $38..
MT
11/22Alnylam Pharmaceuticals Upgraded to Outperform From Sector Perform by RBC After R&D Day..
MT
11/22NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
11/19B. Riley Downgrades Dicerna Pharmaceuticals to Neutral from Buy After Announcing $3.3 B..
MT
11/19RBC Downgrades Dicerna Pharmaceuticals to Sector Perform From Outperform, Lifts PT to $..
MT
11/18SHAREHOLDER ALERT : WeissLaw LLP Investigates Dicerna Pharmaceuticals, Inc.
PR
11/18HC Wainwright Downgrades Dicerna Pharmaceuticals to Neutral From Buy, Adjusts PT to $38..
MT
11/18Health Care Stocks Ending Little Changed in Quiet Trading
MT
More news
News in other languages on DICERNA PHARMACEUTICALS, INC.
11/18Les actions du secteur de la santé terminent peu modifiées dans un marché calme
11/18Les actions du secteur de la santé s'affaiblissent cet après-midi
11/18DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 18.11.2021 - 15.15 Uhr
11/18Les actions du secteur de la santé en hausse jeudi avant le marché
11/18Novo Nordisk übernimmt Biotechnologie-Unternehmen Dicerna Pharmaceuticals
11/18NOVO NORDISK : accord pour l'acquisition de Dicerna
11/18Novo Nordisk va acquérir Dicerna Pharmaceuticals
11/18Novo Nordisk acquiert une entreprise spécialisée dans l'ARN pour 3,3 mrd USD
11/18Dicerna Pharmaceuticals conclut un accord de 3,3 milliards de dollars pour être racheté..
11/18Novo Nordisk kauft für 3,3 Mrd USD Partner Dicerna Pharmaceuticals
More news
Analyst Recommendations on DICERNA PHARMACEUTICALS, INC.
11/22Stifel Downgrades Dicerna Pharmaceuticals to Hold From Buy, Adjusts Price Target to $38..
MT
11/22Alnylam Pharmaceuticals Upgraded to Outperform From Sector Perform by RBC After R&D Day..
MT
11/19B. Riley Downgrades Dicerna Pharmaceuticals to Neutral from Buy After Announcing $3.3 B..
MT
11/19RBC Downgrades Dicerna Pharmaceuticals to Sector Perform From Outperform, Lifts PT to $..
MT
11/18HC Wainwright Downgrades Dicerna Pharmaceuticals to Neutral From Buy, Adjusts PT to $38..
MT
More recommendations
Press releases
11/22SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Dicerna Pharm..
PR
11/18SHAREHOLDER ALERT : WeissLaw LLP Investigates Dicerna Pharmaceuticals, Inc.
PR
11/18SHAREHOLDER ALERT : Ademi LLP investigates whether Dicerna Pharmaceuticals, Inc. has obtai..
PR
11/18DICERNA MERGER INVESTIGATION : Halper Sadeh LLP Announces Investigation Into Whether the S..
BU
11/18DICERNA PHARMACEUTICALS : Novo Nordisk to Acquire Dicerna - Form 8-K
PU
More press releases
Upcoming event on DICERNA PHARMACEUTICALS, INC.